China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)

Market Cap	11.60B
Revenue (ttm)	1.96B
Net Income (ttm)	327.25M
Shares Out	504.25M
EPS (ttm)	0.65
PE Ratio	35.37
Forward PE	19.90
Dividend	0.30 (1.31%)
Ex-Dividend Date	Sep 26, 2025

Volume	4,427,518
Average Volume	4,385,383
Open	23.31
Previous Close	22.95
Day's Range	22.85 - 23.31
52-Week Range	22.58 - 30.76
Beta	0.18
RSI	42.99
Earnings Date	Mar 21, 2026

About SHE:300294

China Resources Boya Bio-pharmaceutical Group Co.,Ltd engages in the blood product businesses in China. It offers blood products, such as human coagulation, human prothrombin, human fibrinogen, human albumin, intravenous human immunoglobulin, and rabies immunoglobulin; and non-blood products. The company also provides bone peptide, oxytocin, heparin sodium, and posterior pituitary injection products. In addition, it engages in research, development, production, and sales of anti-infective, diabetes, and cardiovascular drug; and distributes bloo...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1993
• Employees: 1,938
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300294

Financial Performance

In 2024, SHE:300294's revenue was 1.73 billion, a decrease of -34.58% compared to the previous year's 2.65 billion. Earnings were 396.99 million, an increase of 67.18%.